Nicola Alessandro Iacovelli
University of Milan
Quality of lifeCancerInternal medicineRadiologySurgeryPathologyOncologyStage (cooking)Physical therapyHead and neck cancerInduction chemotherapyChemotherapyNasopharyngeal carcinomaPopulationNuclear medicineNasopharyngeal cancerSinonasal cancerLocally advancedIn patientHead and neckNon endemicRadiation therapyMedicine
68Publications
9H-index
247Citations
Publications 67
Newest
#1Salvatore AlfieriH-Index: 17
#2Carlo ResteghiniH-Index: 13
Last. Paolo BossiH-Index: 39
view all 21 authors...
Source
#1Paolo BossiH-Index: 39
#2Laura PalaH-Index: 10
Last. Lisa LicitraH-Index: 70
view all 19 authors...
Source
#1Cristiana BergaminiH-Index: 20
Last. Lisa LicitraH-Index: 70
view all 8 authors...
We report an unusual case of marked granulomatous reaction developed both before diagnosis and after therapy in a patient with Undifferentiated Nasopharyngeal Carcinoma (UNPC).
Source
#1Salvatore AlfieriH-Index: 17
#2Carlo ResteghiniH-Index: 13
Last. Paolo BossiH-Index: 39
view all 20 authors...
e17054 Background: The value of plasma Epstein Barr Virus (EBV) DNA viral load in nasopharyngeal cancer (NPC) patients before treatment correlates with tumor stage and outcome in endemic areas. The aim of our analysis is to explore the role of EBV DNA in a non-endemic setting where just few experiences have been reported. Methods: The medical records of all the patients with positive EBV encoded RNA (EBER) NPC, treated in our institution from 2006 to 2014 with chemotherapy (CT) concurrent with r...
Source
#1Paolo BossiH-Index: 39
#2Carlo ResteghiniH-Index: 13
Last. Lisa LicitraH-Index: 70
view all 11 authors...
6062 Background: Concurrent chemoradiation (CTRT) produces an advantage in survival as compared with RT alone in locally advanced head and neck squamocellular cancer (HNSCC), while exposing patients (pts) to more severe toxicities. CTRT associated early mortality rate (during and until 90 days after treatment end) has not been consistently described. Methods: We conducted a meta-analysis of phase II-III randomized controlled trials (RCTs), observational studies or case series of HNSCC matching t...
1 CitationsSource
#1Anna CavalloH-Index: 7
#2Tiziana RancatiH-Index: 27
Last. Ester OrlandiH-Index: 23
view all 12 authors...
Source
#1Andrea Greco (University of Milan)H-Index: 15
#2E. OrlandiH-Index: 3
Last. Paolo BossiH-Index: 39
view all 15 authors...
Background Head and neck cancer (HNC) patients can experience symptoms due to the tumor itself or to the treatment, with an impact on health-related quality of life (HRQoL). Patient-reported outcome (PRO) measures pertaining to HRQoL are used in medical research and to support clinical decisions. PRO instrument applicability and cultural adaptation must be tested for each population. The aim of this study is to linguistically validate the Italian translation of the M.D. Anderson Symptom Inventor...
5 CitationsSource